Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ME

23andMe (ME)

23andMe Holding Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ME
DateTimeSourceHeadlineSymbolCompany
01/08/20256:30AMGlobeNewswire Inc.23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted TechnologyNASDAQ:ME23andMe Holding Company
11/21/20243:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
11/20/20246:30AMGlobeNewswire Inc.23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & InflammationNASDAQ:ME23andMe Holding Company
11/15/20248:17PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ME23andMe Holding Company
11/15/20248:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ME23andMe Holding Company
11/15/20243:48PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
11/13/20245:00AMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ME23andMe Holding Company
11/12/20246:30AMGlobeNewswire Inc.23andMe Reports Second Quarter Fiscal Year 2025 Financial ResultsNASDAQ:ME23andMe Holding Company
11/11/20244:30PMGlobeNewswire Inc.23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the FutureNASDAQ:ME23andMe Holding Company
11/07/20244:54PMGlobeNewswire Inc.CORRECTION - 23andMe to Report Q2 FY2025 Financial ResultsNASDAQ:ME23andMe Holding Company
11/07/20246:30AMGlobeNewswire Inc.23andMe to Report Q2 FY2025 Financial ResultsNASDAQ:ME23andMe Holding Company
10/30/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
10/30/20244:00PMGlobeNewswire Inc.23andMe Regains Compliance With Nasdaq Listing RequirementsNASDAQ:ME23andMe Holding Company
10/29/20243:27PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
10/29/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
10/29/20246:30AMGlobeNewswire Inc.23andMe Appoints Three New Independent Directors to BoardNASDAQ:ME23andMe Holding Company
10/17/20243:05PMGlobeNewswire Inc.23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the SouthNASDAQ:ME23andMe Holding Company
10/16/20247:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
10/16/20247:15AMGlobeNewswire Inc.23andMe Announces Completion of 1-for-20 Reverse Stock SplitNASDAQ:ME23andMe Holding Company
10/11/20247:15AMGlobeNewswire Inc.23andMe Announces 1-for-20 Reverse Stock SplitNASDAQ:ME23andMe Holding Company
10/08/20246:00AMGlobeNewswire Inc.23andMe Announces Mathew Knowles as New Brand AmbassadorNASDAQ:ME23andMe Holding Company
09/30/20243:58PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
09/25/20246:30AMGlobeNewswire Inc.23andMe Launches New Genetic Report on Likelihood of Frequent Emotional EatingNASDAQ:ME23andMe Holding Company
09/18/20243:39PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
09/18/20247:10AMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
09/18/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
09/18/20245:13AMIH Market NewsMeta Strengthens Child Privacy on Instagram; Google Overturns $1.7 Billion Antitrust Fine; Snap Updates SpectaclesNASDAQ:ME23andMe Holding Company
09/17/20243:26PMGlobeNewswire Inc.Independent Directors of 23andMe Resign from BoardNASDAQ:ME23andMe Holding Company
09/15/20242:00AMGlobeNewswire Inc.23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 TrialNASDAQ:ME23andMe Holding Company
09/15/20242:00AMGlobeNewswire Inc.23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 StudyNASDAQ:ME23andMe Holding Company
 Showing the most relevant articles for your search:NASDAQ:ME